AI Advances in Antibody and Protein Design Boost Drug Development
TL;DR
AI-designed antibodies are showing promise to significantly enhance drug development processes, potentially leading to faster and more effective treatments.
- AI-designed antibodies promise big boost to drug development Financial Times
- Atomically accurate de novo design of antibodies with RFdiffusion Nature
- ‘Not the end of the story:’ Nobel laureate David Baker on what’s next for de novo design after RFantibody lands in Nature Endpoints News
- Academic AIs make inroads in protein binder design Chemical & Engineering News
- AI and protein language models can accelerate the design of antiviral antibodies News-Medical
Want the full story? Read the original reporting
Read on Financial Times